Cancer Prevention News

The HPV vaccine reduced oral HPV–related infection prevalence among young adults in the United States, according to cross-sectional study results scheduled for presentation at the ASCO Annual Meeting.

An uptake in cancer screening after implementation of the Affordable Care Act in 2014 has shifted the diagnosis of breast, lung and colorectal cancers to an earlier, more treatable stage, according to data scheduled for presentation at the ASCO Annual Meeting.

CHICAGO — Despite improved access to care, racial, ethnic and socioeconomic disparities persist in colorectal cancer screening, particularly among Hispanic people, according to a presentation at Digestive Disease Week.

Applied Proteomics, a company that develops proteome-based blood tests for early detection and monitoring of diseases, has partnered with health care cost management solutions provider MultiPlan, thus expanding access to the company’s colorectal cancer blood test to 50 to 75 million people in the MultiPlan network.

The American Academy of Dermatology designated May as National Melanoma/Skin Cancer Detection and Prevention Month in 1997 to raise awareness on various strategies to prevent skin cancer.

During his presidency, former U.S. President Barack Obama officially proclaimed April as National Cancer Control Month to “move forward in the fight against cancer” by improving the prevention, detection and treatment of cancer.

Follow-up surveillance colonoscopy after resection of intermediate-risk adenomas was associated with a reduced incidence of colorectal cancer in the U.K., according to research published in the Lancet Oncology.

ATLANTA — Since the HPV vaccine was first introduced in the United States in 2006, researchers observed a 71% decline in the prevalence of the four HPV types targeted by vaccination among girls aged 14 to 19 years in 2014. HPV prevalence also decreased by 61% among young women aged 20 to 24 years.

Researchers associated high-quality dietary patterns defined by four different diet quality indexes with a reduced risk for colorectal cancer across a number of racial and ethnic groups.

Patients with a positive fecal immunochemical test who waited more than 10 months to undergo the required follow-up colonoscopy had a higher risk for colorectal cancer and a more advanced stage of disease at diagnosis compared with patients who underwent follow-up colonoscopy within a month, according to new research published in JAMA.